# active_site_0014

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 113 (Glycyl thioester intermediate)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MISAPSPDHLLLEQDLATPEIRCGEIEERWRHIRTSWPHVFFAVSAPQRPNGPKEFGFRFEYTGYRQTPVTAQLWDLEADAPLPHAKWPTGTYVVPSVFRKDWQQGNCLYIPCDRISIQGHTAWLNDHPSRLWQPARGIICYLEQLYELFNQGDYTGLVSA

[Multiple Choices]
A. Position 154 (Nucleophile)
B. Position 113 (Glycyl thioester intermediate)
C. Position 1142 (Proton donor; for dehydratase activity 1)
D. Position 4261 (For beta-ketoacyl synthase 3 activity)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result.

Citations as saved: [H2](#evidence-h2), [H3](#evidence-h3), [C5](#evidence-c5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.


**Missing item-specific fact**

> Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.


**Reason**

> The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length.


### Important caveats

- The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.
- The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.",
    "reason": "The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "H2",
      "H3",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result."
  },
  "important_caveats": [
    "The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.",
    "The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt annotation identifies position 113 as the active site for a glycyl thioester intermediate. The archived record cites a paper whose reference notes mutagenesis of Cys-113. This supports B as a database annotation, though the supplied excerpts do not independently establish the experiment's result.",
    "evidence_ids": ["H2", "H3", "C5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Position 113 is cysteine in the supplied sequence, and a cysteine thiol is chemically suited to form a thioester intermediate. Position 154 is aspartate, making it a substantially less plausible thioester-forming residue; choices C and D are beyond the sequence length.",
    "missing_item_specific_fact": "Direct confirmation that Cys-113 is the active residue in this particular protein is not supplied; that specific assignment is supported by the reviewer-only annotation and its cited literature.",
    "reason": "The sequence and option wording provide a concrete chemical basis favoring B, although they do not by themselves prove the protein-specific functional assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the in-range choices, the cysteine at position 113 fits the stated thioester-intermediate role better than the aspartate at position 154. The other proposed positions exceed the sequence length."
  },
  "important_caveats": [
    "The cited active-site assignment is a UniProt annotation supported by a literature reference; the excerpts are not an independent review of the primary experimental results.",
    "The sequence match is established for the reviewer-only UniProt record, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.


**Missing item-specific fact**

> The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.


**Reason**

> While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices.


### Important caveats

- The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.
- The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.
- Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.
- The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.",
    "reason": "While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A."
  },
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.",
    "The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.",
    "Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.",
    "The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0014",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation (evidence C5, H3) explicitly lists an Active Site at position 113 described as 'Glycyl thioester intermediate' with evidence code ECO:0000305 (curator inference from related entry), supported by reference PubMed:39020165 (Hoer et al., Nature 2024) which reports 'PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113'. Position 113 in the 161-aa sequence is indeed a Cysteine (C), consistent with the catalytic thioester-forming residue of an E2 ubiquitin-conjugating enzyme. The protein is annotated as BilB (Bacterial E2-like ubiquitin protein, EC 2.3.2.-). The annotation is curator-inferred (ECO:0000305) rather than directly experimentally determined, but the referenced paper includes mutagenesis of Cys-113, lending experimental support.",
    "evidence_ids": ["C5", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Options C (position 1142) and D (position 4261) are trivially eliminated because the sequence is only 161 residues long. The protein's short length (~161 aa) is consistent with an E2 ubiquitin-conjugating enzyme, and 'Glycyl thioester intermediate' is terminology specific to ubiquitin/E2 biology. However, the sequence contains four Cysteine residues (positions 23, 108, 113, 141), and general biological knowledge alone cannot determine which Cys is the catalytic one without recognizing the specific E2 catalytic motif or consulting a database. Choosing position 113 over other Cys positions, or over position 154 (Asp, labeled 'Nucleophile'), requires protein-specific annotation knowledge.",
    "missing_item_specific_fact": "The identification of this protein as BilB (E2-like ubiquitin protein) and the specific assignment of Cys-113 as the catalytic glycyl thioester-forming residue, which is a protein-specific annotation from UniProt/PubMed:39020165 and cannot be reliably deduced from the raw 161-aa sequence by general reasoning alone.",
    "reason": "While the short sequence length and the presence of a Cys at position 113 provide weak contextual hints, distinguishing the correct catalytic Cys from the other three Cys residues in the sequence, and confirming the 'glycyl thioester intermediate' functional label, depends on knowing this specific protein's identity and annotation. The trivial elimination of C and D does not constitute meaningful biological reasoning to select B over A."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options C and D are clearly impossible (positions exceed the 161-aa sequence). Option A (position 154, Asp, 'Nucleophile') is a weak distractor: Asp is not typically a nucleophile forming a thioester, and the label is generic. Option B is the only choice consistent with E2 enzyme biochemistry and the actual annotation. No genuine ambiguity among defensible choices."
  },
  "important_caveats": [
    "The active-site annotation carries evidence code ECO:0000305 (inferred by curator from similar data), not direct experimental determination, though the cited paper includes Cys-113 mutagenesis.",
    "The UniProt accession (A0A1I1NU27) was inferred by the reviewer from dataset metadata and was not provided to the evaluated model.",
    "Options C and D reference positions (1142, 4261) far beyond the 161-aa sequence, making them trivially eliminable and reducing the effective discrimination to a binary A-vs-B choice.",
    "The sequence contains multiple Cys residues; identifying the catalytic one from sequence alone without E2 motif knowledge or database lookup is not straightforward."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A1I1NU27` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 11. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:36.666780+00:00.  

```json
{"description":"Glycyl thioester intermediate","evidences":[{"evidenceCode":"ECO:0000305","id":"39020165","source":"PubMed"}],"location":{"end":{"modifier":"EXACT","value":113},"start":{"modifier":"EXACT","value":113}},"type":"Active site"}
```

Source SHA-256: `dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1NU27.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:36.666780+00:00.  

```json
{"citation":{"authors":["Hoer J.","Wolf S.G.","Sorek R."],"citationCrossReferences":[{"database":"PubMed","id":"39020165"},{"database":"DOI","id":"10.1038/s41586-024-07616-5"}],"citationType":"journal article","firstPage":"850","id":"39020165","journal":"Nature","lastPage":"856","publicationDate":"2024","title":"Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly.","volume":"631"},"referenceNumber":2,"referencePositions":["FUNCTION","PROBABLE ACTIVE SITE","MUTAGENESIS OF CYS-113"]}
```

Source SHA-256: `dc1345a3f9e24cec733ddc2f361b20169223c3b2af22cdd9fd503d27975ae399`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)  
**Locator:** `lines 20-26`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:24:42.543529+00:00.  

```text
RN   [2]
RP   FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-113.
RX   PubMed=39020165; DOI=10.1038/s41586-024-07616-5;
RA   Hoer J., Wolf S.G., Sorek R.;
RT   "Bacteria conjugate ubiquitin-like proteins to interfere with phage
RT   assembly.";
RL   Nature 631:850-856(2024).
```

Source SHA-256: `02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1NU27?format=txt&versions=11)  
**Locator:** `lines 69-71`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-02T04:24:42.543529+00:00.  

```text
FT   ACT_SITE        113
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000305|PubMed:39020165"
```

Source SHA-256: `02140c806e50b7c8fba6442df748ac8050a6b50ee7a254e8a2d0deb6a7a2c0c9`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 14. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
